Progesterone withdrawal up-regulates vascular endothelial growth factor receptor type 2 in the superficial zone stroma of the human and macaque endometrium: Potential relevance to menstruation

Journal of Clinical Endocrinology and Metabolism

Volumn 85, Issue 9, 2000, Pages 3442-3452

  Nayak, Nihar R ^a   Critchley, Hilary O D ^b   Slayden, Ov D ^a   Menrad, Andreas ^c   Chwalisz, Kristof ^c   Baird, David T ^b   Brenner, Robert M ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c BAYER PHARMA AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL CELL GROWTH FACTOR; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ENDOMETRIUM; FEMALE; GENE EXPRESSION; HYPOTHESIS; IMMUNOCYTOCHEMISTRY; IN SITU HYBRIDIZATION; MACACA; MENSTRUAL CYCLE; MENSTRUATION DISORDER; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROGESTERONE METABOLISM; STROMA CELL;

ANIMALIA; MACACA; PRIMATES;

EID: 0033678519     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.85.9.3442     Document Type: Article

References (43)

1. Menstruation in intraocular endometrial transplants in the rhesus monkey
2. Choice of treatment for menorrhagia
3. Matrix metalloproteinases as mediators of reproductive function
4. Matrix metalloproteinases in normal menstruation
5. Matrix metalloproteinase expression in Macaca mulatta endometrium: Evidence for zone-specific regulatory tissue gradients
6. Patterns of matrix metalloproteinase expression in cycling endometrium imply differential functions and regulation by steroid hormones
7. Expression and localization of matrilysin, a matrix metalloproteinase, in human endometrium during the reproductive cycle
8. Paracrine action of vascular endothelial growth factor in the human endometrium: Production and target sites, and hormonal regulation
9. Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: Implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis
10. Vascular endothelial growth factor expression in human endometrium is regulated by hypoxia
11. Identification and localization of alternately spliced mRNAs for vascular endothelial growth factor in human uterus and estrogen regulation in endometrial carcinoma cell lines
12. Hypoxia and cAMP stimulate vascular endothelial growth factor (VEGF) in human endometrial stromal cells: Potential relevance to menstruation and endometrial regeneration
13. Role of vascular endothelial growth factor (VEGF) in human cervical ripening: Activation of matrix metalloproteinases (MMPs) via VEGF receptors
14. Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells. Role of flt-1
15. Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells
16. Role of inflammatory mediators in human endometrium during progesterone withdrawal and early pregnancy
17. Effect of cyclofenil on hormonal dynamics, follicular development and cervical mucus in normal and oligomenorrhoeic women
18. Microwave stabilization enhances immunocytochemical detection of estrogen receptor in frozen sections of macaque oviduct
19. Non-human primate models: Artificial menstrual cycles, endometrial matrix metalloproteinases and s.c. endometrial grafts
20. Differential suppression of progesterone receptors by progesterone in the reproductive tract of primate macaques
21. Estrogen receptors, progestin receptors and DNA synthesis in the macaque endometrium during the luteal-follicular transition
22. Novel antibodies directed against the extracellular domain of the human VEGF-receptor type II
23. Proenkephalin gene expression in the primate uterus: Regulation by estradiol in the endometrium
24. Progesterone-dependent expression of keratinocyte growth factor mRNA in stromal cells of the primate endometrium: Keratinocyte growth factor as a progestomedin
25. Expression of vascular endothelial growth factor receptors in the human endometrium: Modulation during the menstrual cycle
26. Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids
27. The arterial pattern of the tunica mucosa of the uterus in macacus rhesus
28. Similarities between the oxygen-sensing mechanisms regulating the expression of vascular endothelial growth factor and erythropoietin
29. Increased gene expression for VEGF and the VEGF receptors KDR/flk and Flt in lungs exposed to acute or to chronic hypoxia. Modulation of gene expression by nitric oxide
30. VEGF, flk-1, and flt-1 expression in a rat myocardial infarction model of angiogenesis
31. Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression
32. Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR, is up-regulated by hypoxia
33. Overexpression of vascular endothelial growth factor in the avian embryo induces hypervascularization and increased vascular permeability without alterations of embryonic pattern formation
34. Up-regulation of flk-1/vascular endothelial growth factor receptor 2 by its ligand in a cerebral slice culture system
35. Strong expression of kinase insert domain-containing receptor, a vascular permeability factor/vascular endothelial growth factor receptor in AIDS-associated Kaposi's sarcoma and cutaneous angiosarcoma
36. Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma
37. The signals and molecular pathways involved in human menstruation, a unique process of tissue destruction and remodelling
38. Plasminogen activator activity during decidualization of human endometrial stromal cells is regulated by plasminogen activator inhibitor 1
39. Prostaglandins and menstruation
40. Matrix matalloproteinase and matrix metalloproteinase inhibitor expression in endometrial stromal cells during progestin-initiated decidualization and menstruation-related progestin withdrawal
41. Human endometrial matrix metalloproteinase-2, a putative menstrual proteinase. Hormonal regulation in cultured stromal cells and messenger RNA expression during the menstrual cycle
42. Menstrual breakdown of human endometrium can be mimicked in vitro and is selectively and reversibly blocked by inhibitors of matrix metalloproteinases